Oligosaccharides in infant nutrition are gut-strengthening nutrition that has been systematically proven to support the infant's immunity and digestion system. In last few years, with increasing consumer inclination towards gut health, it has grown as an issue for numerous people all around the globe. Therefore, 75 percent of the consumers consume those foods promoting a healthy microbiome, and around 56 percent of the consumers like to consume those foods because they digest better. As a result, the demand for oligosaccharides increases in preparing infant formulas because of several qualities such as prebiotic effects, memory improvement, infection prevention, gut health maintenance, and brain growth.
According to Data Bridge Market Research the Oligosaccharides in Infant Nutrition Market witnessed a healthy CAGR of 9.00% from 2022 to 2029.
"Rising popularity of human milk oligosaccharides is expected to drive the market growth"
Human milk oligosaccharides are gaining high popularity for the development and growth of infant because of their potential benefits which are associated with its consumption, such as providing human milk oligosaccharides (HMOs) as a prebiotic to support in maintaining an healthy immune system in infants. This oligosaccharide also aids to improving gut colonization and also prevent form microbial pathogen and foreign particle from adhering to epithelial surfaces. Human milk oligosaccharides (HMOs) are a healthier option for non-lactating mothers because they include all the required nutrients and are essential for the normal growth of infants. Thus, as a result of many benefits and high popularity of human milk oligosaccharides is anticipated to drive the growth of the oligosaccharides in infant nutrition market.
What restraints the growth of oligosaccharides in infant nutrition market?
"Increasing government initiatives to boost breastfeeding over formula"
Growing government initiatives to increase breastfeeding over formula based feeding is projected to hinder the market's growth. The American Academy of Pediatrics and US Dietary Rules for Americans endorse exclusive breastfeeding alert icons for approximately six months and then continuing the breastfeeding until the child is 12 months old or older while introducing other foods alert icons. Furthermore, the natural breastfeeding human milk oligosaccharides (HMOs) supports growth and development more than the artificial synthesized human milk oligosaccharides (HMOs) which will also hamper the market growth.
Segmentation: Oligosaccharides in Infant Nutrition Market
The oligosaccharides in infant nutrition market is segmented on the basis of source, type and form.
- On the basis of source, the oligosaccharides in infant nutrition market is segmented into bacteria, plants, algae, fungi.
- Based on type, the oligosaccharides in infant nutrition market is segmented into galactoligosaccharides, human milk oligosaccharides, fructooligosaccharides.
- On the basis of form, the oligosaccharides in infant nutrition market is segmented into liquid, powder.
Regional Insights: Asia-pacific is expected to dominate the oligosaccharides in infant nutrition market
Asia-Pacific is expected to dominate the market and is expected to grow significantly due to growing disposable income of the population. Moreover, large availability of customer base for human milk oligosaccharides derivative products in this region will further boost the growth of the oligosaccharides in infant nutrition market.
In addition, the North America region is likely to register the highest growth rate during the forecast period of 2022 to 2029 due to increasing demand for occasional calorie sweeteners for confectionary production in this region. Furthermore, large growth in the infant population every year will increase the demand for oligosaccharides in infant nutrition and positively influence the market growth.
To know more about the study visit, https://www.databridgemarketresearch.com/jp/reports/global-oligosaccharides-in-infant-nutrition-market
The Prominent Key Players Operating in the Oligosaccharides in Infant Nutrition Market Include:
- ZuChem Inc. (U.S.)
- Elicityl SA (France)
- Jennewein Biotechnologie GmbH (Germany)
- Royal FrieslandCampina (Netherlands)
- BASF SE (Germany)
- Gnubiotics (Switzerland)
- Inbiose NV (Belgium)
- Glycom A/S (Denmark)
- Glycosyn LLC (U.S.)
- Nestle S.A. (Switzerland)
- DuPont (U.S.)
- DSM (Netherlands)
- Chr. Hansen A/S (Denmark)
- Biosynth Carbosynth (Switzerland)
- Flavors & Fragrances Inc. (U.S.)
- Abbott (U.S.)
- Medolac (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list oligosaccharides in infant nutrition market companies contact, https://www.databridgemarketresearch.com/jp/contact
Research Methodology: Global Oligosaccharides in Infant Nutrition Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
